The anatomic vapor-incision technique (AVIT) and photoselective vaporization of prostate (PVP) with Greenlight 180W-XPS were evaluated in terms of preoperative variables and postoperative functional results.
A total of 174 BPH patients were included in the trial, and 86 cases, 88 cases, and AVIT, respectively, were treated. Pre-, intra-, and postoperative variables that were pertinent were tracked and compared between the two groups.
There were no discernible variations in the baseline characteristics of the 2 groups, and there were no notable intraoperative complications (such as capsule perforation or TUR syndrome). Energy density and consumption in the AVIT group were higher than in the PVP group. In the AVIT group, the operation and laser times were longer than in the PVP group. The incidence of irritative symptoms following surgery was greater in the PVP group compared to the AVIT group. The functional outcomes (IPSS, QoL, prostate volume, and PSA level) over the follow-up period were significantly better in both groups compared to the baseline. In comparison to the PVP group, the AVIT group’s prostate volume and PSA level reductions were noticeably larger.
In comparison to PVP, AVIT is a safe and effective therapy for BPH patients, removing more adenomas and leading to better clinical results. However, to assess the functional results and retreatment rates, long-term follow-up data were required.